The Accountable Produce is Medicine Act of 2026 directs the Center for Medicare and Medicaid Innovation to launch a five-year pilot program that tests a bundled payment model for chronic disease management. This initiative targets patients with conditions such as diabetes, obesity, or cardiovascular disease who reside in rural, medically underserved, or health professional shortage areas. Participating programs must provide a comprehensive package of services, including personalized nutrition counseling, remote patient monitoring, telehealth, and access to nutrient-dense foods, while prioritizing locally grown produce and regenerative agriculture. The model requires regular tracking of patient health metrics like weight and blood pressure, with the option for programs to assume financial risk for performance starting in the third year. All services under this pilot are provided without deductibles or copayments, aiming to evaluate whether these integrated food and medical interventions can improve health outcomes and reduce overall healthcare costs.
The Health Care Fraud Prevention and Enforcement Act mandates increased funding for federal agencies, including the Department of Justice, the Department of Health and Human Services, and the Federal Bureau of Investigation, to combat health care fraud and abuse starting in fiscal year 2027. The bill expands the investigative authority of the HHS Office of Inspector General to cover programs established under the Affordable Care Act and includes the State Children's Health Insurance Program in Medicare-Medicaid data matching efforts. Additionally, it requires the Government Accountability Office to conduct a study on the program's performance and effectiveness, with results due to Congress within 16 months of enactment.
The Provider Reimbursement Stability Act of 2026 aims to create more predictable payment amounts for physicians by modifying how the Centers for Medicare & Medicaid Services calculates fee schedules. It raises the financial threshold for certain budget adjustments from $20 million to $57.64 million starting in 2028 and requires these amounts to be adjusted every five years based on inflation data. The bill also mandates that the government update the costs of staff wages and medical supplies used to calculate payments at least once every five years and limits how much the overall payment rate can change from one year to the next to no more than 2.5 percent. These changes directly affect doctors and healthcare providers who receive Medicare payments, ensuring their reimbursement rates remain more stable and better aligned with actual costs.
The Kidd's Stuttering Act requires Medicaid and CHIP programs to include screening for childhood-onset fluency disorders, such as stuttering, in well-child visits for children aged 2 to 6. Starting in 2028, these screenings must be added to standard health quality measures, and by 2029, states must provide coverage for specific speech therapy services treating these disorders. The law ensures that coverage for stuttering therapy is not more restrictive than coverage for other speech and language disorders and allows these services to be delivered via telehealth. Additionally, managed care organizations and insurance plans must follow established rules to guarantee equal access to these treatments.
This resolution condemns a 2026 Department of Justice opinion that challenges the legal requirement to place people with disabilities in community settings rather than institutions. It directly affects individuals with disabilities who rely on federal protections to live independently and avoid segregation in facilities like nursing homes or psychiatric hospitals. The text affirms that the 1999 Supreme Court ruling in Olmstead v. L.C. mandates that states offer community-based services when appropriate and calls on the Justice Department to rescind its opinion. Additionally, it urges Congress to reverse recent cuts to Medicaid funding that support home and community-based services for people with disabilities.
The Right to IVF Act of 2026 establishes federal protections to ensure individuals can access assisted reproductive technology and intrauterine insemination without state-imposed restrictions, while also mandating that health insurance plans, Medicare, Medicaid, and the Federal Employees Health Benefits program cover these services. The bill defines these procedures broadly to include treatments like egg and embryo freezing and requires coverage regardless of whether a patient has been diagnosed with infertility. It further directs the Department of Defense and the Department of Veterans Affairs to provide fertility preservation and reproductive assistance to uniformed service members and veterans, including funding for egg or sperm retrieval and storage. Additionally, the legislation grants federal courts the authority to challenge and block any state laws that limit access to these reproductive treatments or discriminate against providers and patients based on protected characteristics.
This bill requires all health insurance plans in Hawaii, including Medicaid managed care programs, to cover the cost of continuous glucose monitors for individuals diagnosed with diabetes starting after December 31, 2026. The law mandates that these devices be covered when prescribed by a healthcare professional and deemed medically necessary, regardless of whether the patient uses insulin. Coverage includes the cost of necessary repairs or replacement parts for the monitors, though standard copayments and deductibles may still apply. The legislation aims to improve diabetes management and reduce long-term healthcare costs by ensuring consistent access to this monitoring technology across the state.
This bill requires the Hawaii Department of Education to create an updated plan for maximizing Medicaid reimbursements for administrative and support services provided to students with special needs. The Department must also submit annual reports to the legislature detailing how it meets specific Medicaid claim requirements, such as verifying student eligibility, maintaining proper documentation, and ensuring services are delivered by licensed providers. These reports will include data on the number of students served, the amount of federal funds leveraged, and how the reimbursement money is reinvested. Additionally, the Department must provide training materials and evidence of training for staff involved in delivering these school-based services.
This bill informs the Hawaii Legislature that Governor Josh Green signed Act 221 into law on July 9, 2026. The law expands hospital licensing options by allowing facilities to use accreditation from any Centers for Medicare and Medicaid Services-approved organization, not just The Joint Commission. Under the new rules, hospitals that maintain full accreditation or certification can be exempt from routine state licensing inspections, though the department retains the right to investigate complaints or adverse findings. Additionally, reports and letters from these accrediting bodies will become public information.
This bill establishes a state-funded financial assistance program to cover colorectal cancer screenings and necessary follow-up treatments for Hawaii residents who are uninsured, have inadequate health coverage, or are ineligible for Medicaid. It mandates that all health insurance policies in the state must cover colorectal cancer screenings using approved methods without requiring deductibles, copayments, or other cost-sharing fees. Additionally, the legislation requires insurance providers to inform their customers about the risks of undiagnosed colorectal cancer and encourages them to consult with physicians regarding screening options. The Department of Human Services is tasked with creating an application process for this program, which is initially funded with $1.8 million for the 2026-2027 fiscal year.
